CRMD CorMedix Inc.

8-K Current Report

Filed: March 5, 2026

Health Care

Pharmaceutical Preparations

CorMedix Inc. (CRMD) 8-K current report filed with SEC EDGAR on March 5, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

• Q financial results disclosed via press release (Exhibit 99.1) — see exhibit for specific revenue, earnings, and guidance figures
• Exhibit 99.1 filed but not "Section 18 liable," meaning no legal exposure for forward-looking statements in the release

Other CorMedix Inc. 8-K Filings

8-K Mar 6, 2026

Get deeper insights on CorMedix Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.